Steve Ballmer is Stepping Down from Microsoft

Jacob Harper |

Steve Ballmer has been quite a divisive CEO since he took the reins of Microsoft Corp. (MSFT) from founder Bill Gates in 2000. While Ballmer oversaw successes like the XP Windows operating system, under his guidance the company has struggled to keep up in both the tablet/smartphone market and search, two of the fastest growing components of tech.

Microsoft’s tablet the Surface has been a big disappointment, and Bing has been one of the highest profile flops in the entire tech sector. Microsoft’s attempt to compete with Google, Inc. (GOOG) in search has cost the company around $11 billion.

Ballmer joined Microsoft in 1980 as their first business manager. He became good friends with Gates, and made an unlikely ascent to the head of the company in 2000, when Gates stepped down but stayed on as a “chief software architect” before fully turning the reins over to Ballmer in 2006.

Since assuming total control of the financial and technical developments of Microsoft, Ballmer has been implicated in breeding a divisive, toxic company culture that encouraged departments to compete against one another. The company has attempted to rectify this major issue with the introduction of their “One Microsoft” reorganization initiative.

But what apparently pleases investors more than undoing what Microsoft had become under Ballmer is the very idea that Ballmer will soon be gone enitrely. Immediately following Ballmer’s announcement, Microsoft’s stock skyrocketed.

The stock is up 6.85 percent to hit $34.61 a share.

(image of Steve Ballmer courtesy of Wikimedia Commons)

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Spotlight

BiondVax Pharmaceuticals Ltd.

Biondvax Pharmaceuticals Ltd Ltd is a clinical stage biopharmaceutical company. The Company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.

Events

EQUITIES Emerging Growth and Innovation Forum

EQUITIES Inaugural Emerging Growth and Innovation Forum at Disruptive firm MRY New York City's Flatiron District. The forum is on February 24th from 12:00 pm to 6:00 pm with a…

Learn more

Research

MagneGas Corporation (MNGA)

MagneGas Corporation is an alternative energy company that creates a system that produces hydrogen based fuel through the gasification and sterilization of liquid and liquid waste. ($49 USD)

Learn more

Private Markets

SU Labs Accelerator Seed Fund

We're a fiercely passionate community of entrepreneurs leveraging rapidly accelerating technologies to create a brighter future. Join us in fostering innovation, driving impact and funding the future.

FAB Financial Inc.

Banking is broken. Years ago people who needed business advice would turn to their local bank manager for help. The banker was thought of as a trusted member of the…